IP Library Granted Patent US 9,224,224
Granted Patent B2
US 9,224,224 · App. 13/925,377 · Granted Dec 29, 2015

Methods and systems for predictive clinical planning and design and integrated execution services

Inventors: Donald R Harder (Fishers, IN); Daniel D Siders (Westfield, IN)
Assignee: Quintiles Transnational Corporation
G06T11/206G06F17/10G06F17/30292G06F17/30554G06F19/3406G06F19/363
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,224,224
App. No.
13/925,377
Granted
Dec 29, 2015
Kind
B2
Abstract

Systems and methods for predictive clinical planning, design, and integrated execution services are provided. The system may comprise a database, a web server, an application server, and a client. The system may be used to develop a strategic map of a proposed clinical plan, wherein the clinical plan may include a draft launch label attribute, one or more strategies, and a schema; linking the clinical plan and schema to one or more trials; subsequently linking the trials to one or more objectives and measures; subsequently linking none, one, or a plurality of objectives to none, one, or a plurality of measures; identifying patient criteria and enrolling patients from one or more investigator sites located in one or more countries; and integrating the clinical plan with a clinical plan execution application.

Claims (29)

1. A non-transitory computer-readable medium embodying computer program code for developing a plan for a clinical trial, the computer program code comprising computer executable instructions for:

receiving schema information for the clinical trial from a user interface, the schema information associated with one or more patients for the clinical trial, one or more investigators for the clinical trial, or enrollment criteria for the clinical trial;

generating a schema based at least in part on the schema information, the schema including at least one treatment arm and at least one visit structure for the clinical trial;

receiving patient burden information for the clinical trial, the patient burden information being associated with the at least one visit structure and comprising information about measures to be performed on or by a patient during one or more visits during the clinical trial;

calculating a burden score representing a burden imposed on the patient from participation in the clinical trial, the burden score calculated from the patient burden information;

generating a graphical representation of the schema and the burden score; and

storing the schema and the burden score in a database.

2. The computer-readable medium of claim 1 , wherein the schema information comprises treatment information for a patient population.

3. The computer-readable medium of claim 1 , further comprising a graphical user interface.

4. The computer-readable medium of claim 1 , further comprising computer program code comprising computer executable instructions for automatically updating a schedule of events based on at least a portion of the schema information.

5. The computer-readable medium of claim 1 , further comprising computer program code comprising computer executable instructions for:

providing a schedule of events editor, wherein a schedule of events editor is configured to:

enable a user to designate which of the schema information will be obtained from a patient in a clinical trial on a particular visit; and

determine a cost and the burden associated with obtaining the schema information.

6. The computer-readable medium of claim 5 , wherein the schedule of events editor is configured to access at least a portion of the schema information.

7. A computer-implemented method comprising:

enabling a user to enter information regarding a clinical trial into a schema editor, wherein the information comprises patient information identifying parameters associated with one or more patients for the clinical trial, investigator information associated with one or more investigators for the clinical trial, or enrollment information associated with enrollment criteria for the clinical trial;

storing the information entered into the schema editor;

generating a schema based at least in part on the information entered into the schema editor, the schema including a treatment arm and a visit structure;

receiving patient burden information for the clinical trial, the patient burden information being associated with the visit structure and comprising information about measures to be performed on or by a patient during one or more visits during the clinical trial; and

calculating a burden score representing a burden imposed on the patient from participation in the clinical trial, the burden score calculated from the patient burden information.

8. The computer-implemented method of claim 7 , further comprising:

displaying a visualization of the schema and the burden score.

9. The computer-implemented method of claim 7 , wherein the schema information comprises treatment information for a patient population.

10. The computer-implemented method of claim 7 , wherein the schema editor comprises a graphical user interface.

11. The computer-implemented method of claim 7 , further comprising automatically updating a schedule of events based on at least a portion of the schema information.

12. The computer-implemented method of claim 7 , further comprising providing a schedule of events editor, wherein a schedule of events editor:

enables a user to designate which of the information will be obtained from a patient in a clinical trial on a particular visit; and

determines a cost and the burden associated with obtaining the information.

Assignments (13)
SECURITY INTEREST Recorded Mar 12, 2026
From: IMS SOFTWARE SERVICES LTD.; IQVIA INC.; IQVIA RDS INC.; RULES-BASED MEDICINE, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075047/0061 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTIES INADVERTENTLY NOT INCLUDED IN FILING PREVIOUSLY RECORDED AT REEL: 065709 FRAME: 618. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 6, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065790/0781 →
SECURITY INTEREST Recorded Nov 29, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065710/0253 →
SECURITY INTEREST Recorded Nov 29, 2023
From: IQVIA INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 065709/0618 →
SECURITY INTEREST Recorded May 24, 2023
From: IQVIA INC.; IQVIA RDS INC.; IMS SOFTWARE SERVICES LTD.; Q SQUARED SOLUTIONS HOLDINGS LLC
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 063745/0279 →
CHANGE OF NAME Recorded Oct 9, 2018
From: QUINTILES IMS INCORPORATED
To: IQVIA INC.
Reel/Frame 047207/0276 →
MERGER AND CHANGE OF NAME Recorded Sep 5, 2018
From: QUINTILES TRANSNATIONAL CORP.; IMS HEALTH INCORPORATED
To: QUINTILES IMS INCORPORATED
Reel/Frame 046787/0726 →
SECURITY AGREEMENT Recorded Oct 4, 2016
From: QUINTILES IMS INCORPORATED
To: BANK OF AMERICA, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 040222/0798 →
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2016
From: JPMORGAN CHASE BANK, N.A.
To: ENCORE HEALTH RESOURCES, LLC; EXPRESSION ANALYSIS, INC.; OUTCOME SCIENCES, LLC; QUINTILES TRANSNATIONAL CORP.; QUINTILES, INC.; QUINTILES MARKET INTELLIGENCE, LLC; TARGETED MOLECULAR DIAGNOSTICS, LLC
Reel/Frame 039925/0352 →
SECURITY AGREEMENT Recorded May 14, 2015
From: QUINTILES TRANSNATIONAL CORP.; ENCORE HEALTH RESOURCES, LLC; OUTCOME SCIENCES, LLC; QUINTILES, INC.; QUINTILES MARKET INTELLIGENCE, LLC; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 035664/0180 →
RELEASE OF SECURITY INTEREST Recorded May 13, 2015
From: JPMORGAN CHASE BANK, N.A.
To: QUINTILES TRANSNATIONAL CORP.; TARGETED MOLECULAR DIAGNOSTICS, LLC; QUINTILES, INC.; OUTCOME SCIENCES, INC.; EXPRESSION ANALYSIS, INC.; ENCORE HEALTH RESOURCES, LLC
Reel/Frame 035655/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2015
From: HARDER, DONALD R.; SIDERS, DANIEL D.
To: QUINTILES TRANSNATIONAL CORPORATION
Reel/Frame 034907/0207 →
SECURITY AGREEMENT Recorded Feb 20, 2014
From: QUINTILES TRANSNATIONAL CORP; OUTCOME SCIENCES, INC.; TARGETED MOLECULAR DIAGNOSTICS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 032301/0780 →
Continuity (8)
Provisional Application 61663292 · Jun 22, 2012
Provisional Application 61663057 · Jun 22, 2012
Provisional Application 61663299 · Jun 22, 2012
Provisional Application 61663398 · Jun 22, 2012
Provisional Application 61663219 · Jun 22, 2012
Provisional Application 61663357 · Jun 22, 2012
Provisional Application 61663216 · Jun 22, 2012
Related Publication 20130346454A1 · Dec 26, 2013